Finding winners in biotech, probably the riskiest sector
Investing Experts
00:00
Intro
This chapter explores the investment journey with Tarsus Pharmaceuticals, particularly its lead drug Xdemvi for treating demodex blepharitis. The discussion includes initial skepticism, financial performance, and strategies for navigating risks in biotechnology investments.
Transcript
Play full episode
